Directorate Change

RNS Number : 4328U

Proteome Sciences PLC

16 October 2014

 



Proteome Sciences plc

("Proteome Sciences" or the "Company")

Appointment of Non-Executive Director

16 October, 2014 - The Board of Proteome Sciences is pleased to announce the appointment of Mr. Martin Diggle as a Non-Executive Director with immediate effect.

Mr. Diggle, 52, has worked in finance for over 30 years. He was a director and partner of UBS/Brunswick in Russia until 2003, following which he joined Vulpes Investment Management, where he is currently a director and partner. He is an experienced specialist investor in life sciences and manages the Vulpes Life Sciences Fund, the registered holder of 33,400,217 ordinary shares in Proteome Sciences representing approximately15.6% of the Company's ordinary share capital.

Mr. Diggle is currently a Non-Executive Director of Oxford Biomedica plc and Chronos Therapeutics Limited. Mr Diggle holds an M.A in Philosophy, Politics and Economics from Oxford University.

Save as disclosed above there is no further information required to be disclosed in accordance with paragraph (g) of Schedule 2 of the AIM Rules for companies,

- Ends -

For further information please contact:

Proteome Sciences plc

Christopher Pearce, Executive Chairman                 

Dr. Ian Pike, Chief Operating Officer                   Tel: [phone]

Geoff Ellis, Finance Director

Cenkos - Nominated Adviser

Stephen Keys/Mark Connelly/Callum Davidson      Tel: [phone]

finnCap - Joint Broker

Geoff Nash (Corporate Finance)                          Tel: [phone]

Tony Quirke (Broking)

IKON Associates - Public Relations

Adrian Shaw                                                        Tel: [phone]

 

END

 

 

BOAQELFFZBFFFBZ